Recordati Rare Diseases
11 products tracked · names used in filings: Recordati Rare Diseases
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Maapliv amino acids | Authorised | 2025-07-28 |
| 🇪🇺 | Enjaymo sutimlimab | Authorised | 2022-11-15 |
| 🇪🇺 | Isturisa osilodrostat | Authorised | 2020-01-09 |
| 🇪🇺 | Cystadrops mercaptamine | Authorised | 2017-01-18 |
| 🇪🇺 | Signifor pasireotide | Authorised | 2012-04-24 |
| 🇪🇺 | Vedrop tocofersolan | Authorised | 2009-07-23 |
| 🇪🇺 | Cystadane betaine anhydrous | Authorised | 2007-02-14 |
| 🇪🇺 | Wilzin zinc | Authorised | 2004-10-12 |
| 🇪🇺 | Pedea ibuprofen | Authorised | 2004-07-28 |
| 🇪🇺 | Carbaglu carglumic acid | Authorised | 2003-01-24 |
| 🇪🇺 | Cystagon mercaptamine bitartrate | Authorised | 1997-06-23 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.